Inactive Instrument

News Presbia PLC Nasdaq

Equities

Presbia PLC(OTCPK:LENS.F) dropped from S&P TMI Index	19-04-29	CI
Presbia PLC Announces Management Changes	19-04-26	CI
Presbia PLC(OTCPK:LENS.F) dropped from NASDAQ Composite Index	19-04-24	CI
Presbia PLC Announces Executive Changes	19-04-22	CI
Presbia plc Reports Earnings Results for the Full Year Ended December 31, 2018	19-04-12	CI
Presbia PLC Auditor Raises 'Going Concern' Doubt	19-04-11	CI
Presbia PLC Announces Management Changes	19-02-01	CI
Presbia PLC announced that it has received $0.1 million in funding	18-12-09	CI
Presbia PLC announced that it has received $0.1 million in funding	18-04-11	CI
Presbia PLC Auditor Raises 'Going Concern' Doubt	18-03-29	CI
Presbia plc Announces the Resignation of Magda Michna as Chief Clinical Officer, Effective March 30, 2018	18-03-21	CI
Presbia PLC Announces Resignation of Vladimir Feingold from the Board of Directors	18-02-21	CI
Presbia PLC Announces New Management Appointments	18-02-13	CI
Presbia PLC Announces Management Changes	18-01-09	CI
Presbia PLC Announces Management Changes	17-12-14	CI
Presbia PLC Announces Management Changes	17-01-18	CI
Presbia PLC Provides Update on U.S. Staged Pivotal Clinical Trial	16-12-22	CI
Presbia Seeks Acqusitions	16-12-05	CI
Presbia PLC Appoints Jarett Fenton as Chief Financial Officer	16-06-16	CI
Presbia PLC Completes 6-Month Post-Operative Visits	16-05-31	CI

No results for this search